BackgroundAntiretroviral treatment (ART) options for young children co-infected with HIV and tuberculosis are limited in resource-poor settings due to limited data on the use of efavirenz (EFV). Using
Objective To quantify the impact of antiretroviral therapy (ART) on mortality in HIV-positive people during tuberculosis (TB) treatment. Design We conducted a systematic literature review and meta-ana
Results of mycobacterial and bacterial/viral cultures on biopsy specimens (TB Clinical Information CRF) Study Description Describes the demographic, clinical, immunologic, and virologic characteristic